Primary Job Title Co-Founder Primary Organization 
OncoFusion Therapeutics
Gender Male
Shaomeng Wang is a co-founder of Ascenta and is currently the Warner-Lambert/Parke-Davis Professor in Medicine at the University of Michigan Medical School and professor of medicinal chemistry, internal medicine and pharmacology at the University of Michigan. Shaomeng Wang received his B.S. in Chemistry from Peking University in 1986 and his
Ph.D. in Chemistry from Case Western Reserve University in 1992. Shaomeng Wang did his postdoctoral training in drug design at the National Cancer Institute, NIH between 1992-1996. Shaomeng Wang was Assistant Professor at Georgetown University from 1996-2000 and Associate Professor from 2000-2001. Shaomeng Wang joined the faculty at the University of Michigan Medical School as a tenured Associate Professor in 2001 and was promoted to Professor in 2006. Shaomeng Wang was named the Warner-Lambert/Parke-Davis Professor in Medicine at the University of Michigan Medical School in 2007.
Shaomeng Wang serves as the director of the Cancer Drug Discovery program and co-director of the Molecular Therapeutics Program at the University of Michigan Comprehensive Cancer Center. Shaomeng Wang is the Principal Investigator of a National Cooperative Drug Discovery Group grant from the National Cancer Institute, NIH. Shaomeng Wang has published more than 170 papers in peer-reviewed scientific journals and 100 meeting abstracts, and is an inventor on 30 international and US patents and patent applications. Shaomeng Wang is an innovative leader in structure-based design of target-specific small-molecule therapeutics.
